Seacoast Capital, a lower middle market non-control growth capital investor, completed a $30m investment in SkinCure Oncology, a medical clinic in Burr Ridge, Illinois. “Seacoast Capital’s investment in SkinCure seemed a natural partnership. Given their long-tenured experience in healthcare services, the Seacoast team was quickly able to evaluate our business model and recognize us for the opportunities in front of us. We look forward to a long partnership with Tom, David, and the rest of the Seacoast family,” Kerwin Brandt, SkinCure CEO.